Aprezo 30mg Tablet contains an active component called Apremilast. It is indicated for treating moderate to severe plaque psoriasis, a chronic autoimmune condition characterised by patches of abnormal skin. The Aprezo Tablet can help reduce the affected skin's redness, scaling, and thickness. It is also used to treat active psoriatic arthritis, a type of arthritis that affects some people with psoriasis. This medication should not be used in individuals with a known hypersensitivity or allergic reaction to it or its components. It is associated with risks to the developing fetus and is contraindicated during pregnancy. The dosage adjustment of Aprezo 30mg Tablet is required in patients with severe renal impairment because the drug is primarily excreted through the kidneys. There is limited information about using this Tab Aprezo 30 mg in the elderly population. Therefore, caution should be exercised in older adults, and the dosage may need adjustment based on individual health conditions and renal function. It has not been studied in children under 18, and its safety and efficacy in this population have yet to be established.